Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Carcinoma and meta-analysis and NQO1[original query] |
---|
NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3967-79. Lou Yuqing, Li Rong, Xiong Liwen, Gu Aiqin, Shi Chunlei, Chu Tianqing, Zhang Xueyan, Gu Ping, Zhong Hua, Wen Shaojun, Han Baoh |
NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis. BMC medical genetics 2013 14 . Yanling H, Yuhong Z, Wenwu H, Lei X, Mingwu C |
The NQO1 C609T polymorphism and hepatocellular carcinoma risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Aug 35 (8): 7343-50. Fan Yonggang, Hu Dingwen, Feng Bing, Wang W |
Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population. Asian Pacific journal of cancer prevention : APJCP 2015 16 (5): 1821-5. Zhao Hong, Zou Li-Wei, Zheng Sui-Sheng, Geng Xiao-Pi |
The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies. Cancer investigation 2015 Mar 33 (2): 39-40. Zhang Yan, Yang Dong, Zhu Jin-Hong, Chen Min-Bin, Shen Wen-Xiang, He Ji |
Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinoma. Oncotarget 2016 Jul 7 (29): 45757-45763. Dong Dong, Zou Yang, Zhang Pan, Wu Zhiho |
Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls. Frontiers in oncology 2022 11 12 980897. Zhou Hangsheng, Wan Hongyuan, Zhu Lijie, Mi Yuanyu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: